Explore / Peer-reviewed article
Peer-reviewed article

Innovative Pharmacological Approaches to Eating Disorder Treatment.

Keshen A, Touyz S, Lacroix E, Hay P, McElroy SL

The Psychiatric clinics of North AmericaSep 24, 2025Canada, Australia, United States0 citationsDOI: 10.1016/j.psc.2025.08.014

Abstract

This article explores innovative pharmacologic treatments for eating disorders, focusing on psychedelics, stimulant medications, and other emerging therapies. Preliminary evidence for psychedelics (eg, psilocybin) highlight their potential to enhance cognitive flexibility and support psychological interventions in some eating disorders (eg, anorexia nervosa). Stimulants like lisdexamfetamine offer benefits for binge-eating disorder, while medications for avoidant/restrictive food intake disorder and bulimia nervosa remain understudied. The study underscores the need for robust clinical trials to evaluate these approaches and advocates for integrating novel treatments into existing therapeutic frameworks to address the complex biological and psychological dimensions of eating disorders.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinEating disorders

Keywords

Anorexia NervosaPharmacotherapyStimulant MedicationsBulimia NervosaBinge-eating DisorderPsychedelicsAvoidant/restrictive Food Intake Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.